Our Stories

Teva scientist interacting with a large green abstract network graphic illustrating biological pathways and potential pathways for business growth.

Sustaining Teva’s Generics Powerhouse in the Acceleration Phase

podcast

Teva in 2025: Innovation drives third consecutive year of growth